An Exploratory Pilot Study into the Association Between Microcirculatory Parameters Derived by MRI-based Pharmacokinetic Analysis and Glucose Utilization Estimated by PET-CT Imaging in Head and Neck Cancer

Overview

Journal Eur Radiol

Specialty Radiology

Date 2010 May 6

PMID 20443116

Citations 22

Authors

Sotirios Bisdas

Oliver Seitz

Markus Middendorp

Nicole Chambron-Pinho

Theodosios Bisdas

Thomas J Vogl

Renate Hammerstingl

Ulrike Ernemann

Martin G Mack

Affiliations

Soon will be listed here.

Abstract

Objectives: To examine the feasibility of deriving quantitative microcirculatory parameters and to investigate the relationship between vascular and metabolic characteristics of head and neck tumours in vivo, using dynamic contrast-enhanced (DCE) MRI and fluorodeoxyglucose (FDG) PET imaging.

Methods: Twenty-seven patients with primary squamous cell carcinoma (SCCA) underwent DCE-MRI and combined PET/CT imaging. DCE-MRI data were post-processed by using commercially available software. Transfer constant (K (trans)), extravascular extracellular blood volume (v (e)), transfer constant from the extracellular extravascular space to plasma (k (ep)) and iAUC (initial area under the signal intensity-time curve) were calculated. 3D static PET data were acquired and standardised uptake values (SUV) calculated.

Results: All microcirculatory parameters in tumours were higher than in normal muscle tissue (P ≤ 0.0019). Significant correlations were shown between k (ep) and K (trans) (ρ = 0.77), v (e) and k (ep) (ρ = -0.7), and iAUC and v (e) (ρ = 0.53). Significant correlations were observed for SUV(mean) and v (e) as well as iAUC (ρ = 0.42 and ρ = 0.66, respectively). SUV(max) was significantly correlated with iAUC (ρ = 0.69).

Conclusions: The demonstrated relationships between vascular and metabolic characteristics of primary SCCA imply a complex interaction between vascular delivery characteristics and tumour metabolism. The lack of correlation between SUV and K (trans)/k (ep) suggests that both diagnostic techniques may provide complementary information.

Citing Articles

Translation of dynamic contrast-enhanced imaging onto a magnetic resonance-guided linear accelerator in patients with head and neck cancer.

Dubec M, Berks M, Price J, McDaid L, Gaffney J, Little R Phys Imaging Radiat Oncol. 2025; 33():100689.

PMID: 39802650 PMC: 11721217. DOI: 10.1016/j.phro.2024.100689.

The correlations between dynamic contrast enhanced magnetic resonance imaging and immunohistochemical data in head and neck squamous cell carcinomas.

Karabay N, Bulbul H, Dogan E, Ikiz A, Bulbul G, Sarioglu S Turk J Med Sci. 2023; 52(6):1950-1957.

PMID: 36945990 PMC: 10390131. DOI: 10.55730/1300-0144.5543.

Microenvironmental Factors in Oral Cavity Squamous Cell Carcinoma Undergoing Surgery: Correlation with Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced MRI.

Vidiri A, Ascione A, Piludu F, Polito E, Gallo E, Covello R Cancers (Basel). 2023; 15(1).

PMID: 36612011 PMC: 9817509. DOI: 10.3390/cancers15010015.

Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel.

Romeo V, Stanzione A, Ugga L, Cuocolo R, Cocozza S, Quarantelli M Insights Imaging. 2022; 13(1):198.

PMID: 36528678 PMC: 9759606. DOI: 10.1186/s13244-022-01317-1.

Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI.

DUrso P, Farneti A, Marucci L, Marzi S, Piludu F, Vidiri A Cancers (Basel). 2022; 14(10).

PMID: 35626084 PMC: 9139324. DOI: 10.3390/cancers14102477.

References

van Laarhoven H, Klomp D, Rijpkema M, Kamm Y, Wagener D, Barentsz J . Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil. NMR Biomed. 2006; 20(2):128-40. DOI: 10.1002/nbm.1098. View

Rumboldt Z, Al-Okaili R, Deveikis J . Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol. 2005; 26(5):1178-85. PMC: 8158592. View

Newbold K, Castellano I, Charles-Edwards E, Mears D, Sohaib A, Leach M . An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2008; 74(1):29-37. DOI: 10.1016/j.ijrobp.2008.07.039. View

Tseng J, Dunnwald L, Schubert E, Link J, Minoshima S, Muzi M . 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med. 2004; 45(11):1829-37. View

Escott E, Rao V, Ko W, Guitierrez J . Comparison of dynamic contrast-enhanced gradient-echo and spin-echo sequences in MR of head and neck neoplasms. AJNR Am J Neuroradiol. 1997; 18(8):1411-9. PMC: 8338140. View

Avril N, Bense S, Ziegler S, Dose J, Weber W, Laubenbacher C . Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med. 1997; 38(8):1186-91. View

Zhou R, Pickup S, Yankeelov T, Springer Jr C, Glickson J . Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med. 2004; 52(2):248-57. DOI: 10.1002/mrm.20143. View

Zhu X, Li K, Kamaly-Asl I, Checkley D, Tessier J, Waterton J . Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging. 2000; 11(6):575-85. DOI: 10.1002/1522-2586(200006)11:6<575::aid-jmri2>3.0.co;2-1. View

Jain R . Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987; 6(4):559-93. DOI: 10.1007/BF00047468. View

10.

Parker G, Suckling J, Tanner S, Padhani A, Revell P, Husband J . Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging. 1997; 7(3):564-74. DOI: 10.1002/jmri.1880070318. View

11.

Tofts P, Brix G, Buckley D, Evelhoch J, Henderson E, Knopp M . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999; 10(3):223-32. DOI: 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s. View

12.

Torizuka T, Zasadny K, Recker B, Wahl R . Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies. Radiology. 1998; 207(3):767-74. DOI: 10.1148/radiology.207.3.9609902. View

13.

Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl T . 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology. 2009; 51(10):677-86. DOI: 10.1007/s00234-009-0586-8. View

14.

George M, Padhani A, Brown G, Tait D, Eccles S, Swift R . Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg. 2001; 88(12):1628-36. DOI: 10.1046/j.0007-1323.2001.01947.x. View

15.

Baek C, Chung M, Son Y, Choi J, Kim H, Yim Y . Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images. J Nucl Med. 2008; 49(9):1422-8. DOI: 10.2967/jnumed.108.051649. View

16.

Bisdas S, Rumboldt Z, Wagenblast J, Baghi M, Koh T, Hambek M . Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements. AJNR Am J Neuroradiol. 2009; 30(4):793-9. PMC: 7051758. DOI: 10.3174/ajnr.A1449. View

17.

Zhao J, Salmon H, Sarntinoranont M . Effect of heterogeneous vasculature on interstitial transport within a solid tumor. Microvasc Res. 2007; 73(3):224-36. DOI: 10.1016/j.mvr.2006.12.003. View

18.

Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji S . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol. 2007; 28(2):328-34. PMC: 7977386. View

19.

Noworolski S, Fischbein N, Kaplan M, Lu Y, Nelson S, Carvajal L . Challenges in dynamic contrast-enhanced MRI imaging of cervical lymph nodes to detect metastatic disease. J Magn Reson Imaging. 2003; 17(4):455-62. DOI: 10.1002/jmri.10280. View

20.

Gandhi D, Hoeffner E, Carlos R, Case I, Mukherji S . Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr. 2003; 27(5):687-93. DOI: 10.1097/00004728-200309000-00005. View